Use of botulinum toxin in Meige's disease.

Riv Neurol

Cattedra di Neuropatologia e Psicopatologia, Istituto delle Malattie Nervose e Mentali, Università, Firenze.

Published: June 1989

Four patients with severe Meige's disease (blepharospasm-oromandibular dystonia) have been treated, after having given an informed consent, by local injections of purified botulinum toxin type "A". Previous systemic therapy with anticholinergics, dopamine antagonists and other drugs had been unsuccessful in all these subjects. Each patient was treated by saline solution injected with the same method as botulinum toxin, just once. The self-evaluation of patients and the clinical evaluation that some of us- unaware of the kind of therapy which had been performed- gave to the symptoms on the basis of videotapes, for each session of injection, showed that the injections of botulinum toxin are effective in the treatment of such disorder. The duration of the beneficial effect was slightly shorter in these patients than in patients with blepharospasm treated by the same method.

Download full-text PDF

Source

Publication Analysis

Top Keywords

botulinum toxin
16
meige's disease
8
botulinum
4
toxin meige's
4
patients
4
disease patients
4
patients severe
4
severe meige's
4
disease blepharospasm-oromandibular
4
blepharospasm-oromandibular dystonia
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!